1 – 21 of 21
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
(
- Contribution to journal › Article
- 2014
-
Mark
Minimizing risk of hypomethylating agent failure in patients with higher-risk MDS and practical management recommendations.
2014) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 38(12). p.1381-1391(
- Contribution to journal › Scientific review
-
Mark
Identification of B-cell lymphoma subsets by plasma protein profiling using recombinant antibody microarrays.
(
- Contribution to journal › Article
- 2013
-
Mark
Leukemia associated mutant Wilms' tumor gene 1 protein promotes expansion of human hematopoietic progenitor cells.
2013) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 37(10). p.1341-1349(
- Contribution to journal › Article
- 2012
-
Mark
Additional aberrations of the ETV6 and RUNX1 genes have no prognostic impact in 229 t(12;21)(p13;q22)-positive B-cell precursor acute lymphoblastic leukaemias treated according to the NOPHO-ALL-2000 protocol
(
- Contribution to journal › Letter
-
Mark
Nucleolar proteins with altered expression in leukemic cell lines.
(
- Contribution to journal › Article
- 2011
-
Mark
TP53 Mutations are infrequent in newly diagnosed chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
t(9;11)(p22;p15) [NUP98/PSIP1] is a poor prognostic marker associated with de novo acute myeloid leukaemia expressing both mature and immature surface antigens.
(
- Contribution to journal › Letter
- 2010
-
Mark
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Exploring novel therapeutic options in T-LGL, including epigenetic modulation: A case report.
(
- Contribution to journal › Letter
-
Mark
A comment on Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia
2010) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 34(9). p.1253-1253(
- Contribution to journal › Letter
- 2009
-
Mark
Maintenance treatment with 5-azacitidine for patients with high risk myelodysplastic syndrome (MDS) or acute myeloid leukemia following MDS (MDS-AML) in complete remission (CR) after induction chemotherapy
2009) 10th International Symposium on Myelodysplastic Syndromes In Leukemia Research 33(Suppl 1). p.49-50(
- Contribution to journal › Published meeting abstract
-
Mark
Expression of p53 or cytoplasmic nucleophosmine associated with increased risk of disease progression in myelodysplastic syndrome with isolated del(5q)
(
- Contribution to journal › Published meeting abstract
-
Mark
In vitro cellular drug sensitivity at diagnosis is correlated to minimal residual disease at end of induction therapy in childhood acute lymphoblastic leukemia
(
- Contribution to journal › Article
-
Mark
Smoking as a risk factor for myelodysplastic syndromes and acute myeloid leukemia and its relation to cytogenetic findings: A case-control study.
2009) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis Nov 17. p.788-791(
- Contribution to journal › Article
- 2008
-
Mark
The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia
(
- Contribution to journal › Article
- 2007
-
Mark
Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow.
2007) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 31(7). p.995-1001(
- Contribution to journal › Article
- 2006
-
Mark
Cyclin A1 expression and associations with disease characteristics in childhood acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia
2006) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 30(8). p.1043-1047(
- Contribution to journal › Article
- 2005
-
Mark
Transcriptional profiling and assessment of cell lines as in vitro models for mantle cell lymphoma
(
- Contribution to journal › Article
- 2001
-
Mark
Smoking and acute myeloid leukemia: associations with morphology and karyotypic patterns and evaluation of dose-response relations
2001) In Leukemia Research: A Forum for Studies on Leukemia and Normal Hemopoiesis 25(10). p.865-872(
- Contribution to journal › Article